> top > docs > PMC:3585731 > spans > 29992-30207 > annotations

PMC:3585731 / 29992-30207 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T31279 22-31 VB denotes performed
T31278 17-21 VB denotes were
T31277 10-16 NN denotes assays
T31276 0-9 NN denotes Viability
T31312 204-214 NN denotes antibodies
T31311 194-203 JJ denotes indicated
T31310 190-193 DT denotes the
T31309 184-189 VB denotes using
T31308 179-183 NN denotes blot
T31307 171-178 JJ denotes western
T31306 168-170 IN denotes by
T31305 159-167 VB denotes followed
T31304 157-158 -COMMA- denotes ,
T31303 155-157 NN denotes hr
T31302 153-154 CD denotes 9
T31301 149-152 IN denotes for
T31300 138-148 NN denotes conditions
T31299 133-137 JJ denotes free
T31298 127-132 NN denotes serum
T31297 121-126 IN denotes under
T31296 115-120 NN denotes Nec-1
T31295 108-114 CC denotes and/or
T31294 99-107 NN denotes zVAD.fmk
T31293 94-98 IN denotes with
T31292 86-93 VB denotes treated
T31291 81-85 VB denotes were
T31290 75-80 NN denotes cells
T31289 69-74 NN denotes K179M
T31288 61-68 JJ denotes Myr-Akt
T31287 57-60 CC denotes and
T31286 49-56 NN denotes Myr-Akt
T31285 47-48 -RRB- denotes )
T31284 46-47 NN denotes C
T31283 45-46 -LRB- denotes (
T31282 41-44 NN denotes hr.
T31281 38-40 CD denotes 24
T31280 32-37 IN denotes after
R21602 T31277 T31276 arg1Of assays,Viability
R21603 T31277 T31278 arg1Of assays,were
R21604 T31277 T31279 arg2Of assays,performed
R21605 T31279 T31278 arg2Of performed,were
R21606 T31279 T31280 arg1Of performed,after
R21607 T31282 T31280 arg2Of hr.,after
R21608 T31282 T31281 arg1Of hr.,24
R21609 T31282 T31283 arg1Of hr.,(
R21610 T31282 T31291 modOf hr.,were
R21611 T31284 T31283 arg2Of C,(
R21612 T31285 T31283 arg3Of ),(
R21613 T31286 T31287 arg1Of Myr-Akt,and
R21614 T31287 T31291 arg1Of and,were
R21615 T31287 T31292 arg2Of and,treated
R21616 T31290 T31287 arg2Of cells,and
R21617 T31290 T31288 arg1Of cells,Myr-Akt
R21618 T31290 T31289 arg1Of cells,K179M
R21619 T31292 T31291 arg2Of treated,were
R21620 T31292 T31293 arg1Of treated,with
R21621 T31292 T31297 arg1Of treated,under
R21622 T31292 T31301 arg1Of treated,for
R21623 T31292 T31304 arg1Of treated,","
R21624 T31292 T31305 modOf treated,followed
R21625 T31294 T31295 arg1Of zVAD.fmk,and/or
R21626 T31295 T31293 arg2Of and/or,with
R21627 T31296 T31295 arg2Of Nec-1,and/or
R21628 T31300 T31297 arg2Of conditions,under
R21629 T31300 T31298 arg1Of conditions,serum
R21630 T31300 T31299 arg1Of conditions,free
R21631 T31303 T31301 arg2Of hr,for
R21632 T31303 T31302 arg1Of hr,9
R21633 T31308 T31305 arg1Of blot,followed
R21634 T31308 T31306 arg2Of blot,by
R21635 T31308 T31307 arg1Of blot,western
R21636 T31308 T31309 arg1Of blot,using
R21637 T31312 T31309 arg2Of antibodies,using
R21638 T31312 T31310 arg1Of antibodies,the
R21639 T31312 T31311 arg1Of antibodies,indicated

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T31458 65-68 http://www.uniprot.org/uniprot/Q9Y243 denotes Akt
T31457 53-56 http://www.uniprot.org/uniprot/Q9Y243 denotes Akt
T31448 65-68 http://www.uniprot.org/uniprot/P31751 denotes Akt
T31447 53-56 http://www.uniprot.org/uniprot/P31751 denotes Akt
T31438 65-68 http://www.uniprot.org/uniprot/P31749 denotes Akt
T31437 53-56 http://www.uniprot.org/uniprot/P31749 denotes Akt

UBERON-AE

Id Subject Object Predicate Lexical cue
T31181 127-132 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

GO-MF

Id Subject Object Predicate Lexical cue
T31201 204-214 http://purl.obolibrary.org/obo/GO_0003823 denotes antibodies

GO-CC

Id Subject Object Predicate Lexical cue
T31207 204-214 http://purl.obolibrary.org/obo/GO_0042571 denotes antibodies
T31206 204-214 http://purl.obolibrary.org/obo/GO_0019815 denotes antibodies
T31203 75-80 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T31187 0-215 Sentence denotes Viability assays were performed after 24 hr. (C) Myr-Akt and Myr-Akt K179M cells were treated with zVAD.fmk and/or Nec-1 under serum free conditions for 9 hr, followed by western blot using the indicated antibodies.
T189 0-215 Sentence denotes Viability assays were performed after 24 hr. (C) Myr-Akt and Myr-Akt K179M cells were treated with zVAD.fmk and/or Nec-1 under serum free conditions for 9 hr, followed by western blot using the indicated antibodies.

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T31778 49-56 Entity denotes Myr-Akt
T31776 61-80 Entity denotes Myr-Akt K179M cells
T31774 61-80 Protein denotes Myr-Akt K179M cells
T31767 61-80 Entity denotes Myr-Akt K179M cells
T31765 115-157 Protein denotes Nec-1 under serum free conditions for 9 hr
T31755 99-107 Entity denotes zVAD.fmk
T31751 204-214 Entity denotes antibodies
T31739 49-56 Protein denotes Myr-Akt

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T31574 214-215 . denotes .
T31573 204-214 NNS denotes antibodies
T31572 194-203 VBN denotes indicated
T31571 190-193 DT denotes the
T31570 184-189 VBG denotes using
T31569 179-183 NN denotes blot
T31568 171-178 JJ denotes western
T31567 168-170 IN denotes by
T31566 159-167 VBN denotes followed
T31565 157-158 , denotes ,
T31564 155-157 NN denotes hr
T31563 153-154 CD denotes 9
T31562 149-152 IN denotes for
T31561 138-148 NNS denotes conditions
T31560 133-137 JJ denotes free
T31559 127-132 NN denotes serum
T31558 121-126 IN denotes under
T31557 115-120 NNP denotes Nec-1
T31556 108-114 CC denotes and/or
T31555 99-107 NNP denotes zVAD.fmk
T31554 94-98 IN denotes with
T31553 86-93 VBN denotes treated
T31552 81-85 VBD denotes were
T31551 75-80 NNS denotes cells
T31550 69-74 NNP denotes K179M
T31549 61-68 NNP denotes Myr-Akt
T31548 57-60 CC denotes and
T31547 49-56 NNP denotes Myr-Akt
T31546 47-48 -RRB- denotes )
T31545 46-47 NNP denotes C
T31544 45-46 -LRB- denotes (
T31543 43-44 . denotes .
T31542 41-43 NN denotes hr
T31541 38-40 CD denotes 24
T31540 32-37 IN denotes after
T31539 22-31 VBN denotes performed
T31538 17-21 VBD denotes were
T31537 10-16 NNS denotes assays
T31536 0-9 NN denotes Viability
R21829 T31536 T31537 compound Viability,assays
R21830 T31537 T31539 nsubjpass assays,performed
R21831 T31538 T31539 auxpass were,performed
R21832 T31539 T31539 ROOT performed,performed
R21833 T31540 T31539 prep after,performed
R21834 T31541 T31542 nummod 24,hr
R21835 T31542 T31540 pobj hr,after
R21836 T31543 T31539 punct .,performed
R21837 T31544 T31547 punct (,Myr-Akt
R21838 T31545 T31547 nmod C,Myr-Akt
R21839 T31546 T31547 punct ),Myr-Akt
R21840 T31547 T31551 nmod Myr-Akt,cells
R21841 T31548 T31547 cc and,Myr-Akt
R21842 T31549 T31550 compound Myr-Akt,K179M
R21843 T31550 T31547 conj K179M,Myr-Akt
R21844 T31551 T31553 nsubjpass cells,treated
R21845 T31552 T31553 auxpass were,treated
R21846 T31553 T31553 ROOT treated,treated
R21847 T31554 T31553 prep with,treated
R21848 T31555 T31554 pobj zVAD.fmk,with
R21849 T31556 T31555 cc and/or,zVAD.fmk
R21850 T31557 T31555 conj Nec-1,zVAD.fmk
R21851 T31558 T31553 prep under,treated
R21852 T31559 T31558 pobj serum,under
R21853 T31560 T31561 amod free,conditions
R21854 T31561 T31558 pobj conditions,under
R21855 T31562 T31553 prep for,treated
R21856 T31563 T31564 nummod 9,hr
R21857 T31564 T31562 pobj hr,for
R21858 T31565 T31553 punct ",",treated
R21859 T31566 T31553 advcl followed,treated
R21860 T31567 T31566 agent by,followed
R21861 T31568 T31569 amod western,blot
R21862 T31569 T31567 pobj blot,by
R21863 T31570 T31566 advcl using,followed
R21864 T31571 T31573 det the,antibodies
R21865 T31572 T31573 amod indicated,antibodies
R21866 T31573 T31570 dobj antibodies,using
R21867 T31574 T31553 punct .,treated

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T31711 99-107 Protein denotes zVAD.fmk
T31710 65-68 Protein denotes Akt
T31709 61-64 Protein denotes Myr
T31708 53-56 Protein denotes Akt
T31707 49-52 Protein denotes Myr